Atelectasis primary prevention

Revision as of 15:59, 20 February 2018 by Sudarshana Datta (talk | contribs)
Jump to navigation Jump to search

Atelectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atelectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Atelectasis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atelectasis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atelectasis primary prevention

CDC on Atelectasis primary prevention

Atelectasis primary prevention in the news

Blogs on Atelectasis primary prevention

Directions to Hospitals Treating Atelectasis

Risk calculators and risk factors for Atelectasis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

  • There are no established measures for the primary prevention of [disease name].
  • There are no available vaccines against [disease name].

OR

  • Effective measures for the primary prevention of [disease name] include:
    • [Measure1]
    • [Measure2]
    • [Measure3]

Postoperative atelectasis: Judicious use of anaesthetic agents known to cause narcosis Sparing use of narcotics to avoid depression of the cough reflex Use of epidural analgesia in patients with underlying pulmonary disease is advocated Incentive spirometry Early ambulation Humidifiers Nebulized bronchodilators Chest physiotherapy Patient should be instructed to inspire deeply and cough Supplemental oxygen: arterial oxygen saturation of greater than 90 % Intubation and mechanical support Positive pressure ventilation CPAP Antitussive therapy


Prevention of further atelectasis involves: Prophylactic maneuvers preferred in patients include: (1) Placement of the patient in the lateral decubitus position to allow drainage

(2) Chest physiotherapy

Incentive spirometry Deep breathing exercises Coughing exercises Instructions for early ambulation


References

Template:WH Template:WS